Moderna美股盘前涨超50%，公司与默沙东宣布黑色素瘤皮肤癌疫苗在大型试验中达到目标影响。
Moderna美股盘前涨超50%，公司与默沙东宣布黑色素瘤皮肤癌疫苗在大型试验中达到目标影响。
其他语言标题
- EnglishModerna's US-listed shares surged over 50% in pre-market trading, as the company and Merck announced that their melanoma skin cancer vaccine met its goals in a large-scale trial.